Benzodiazepines, methadone and buprenorphine: interactions and clinical management
Spremljeno u:
Lintzeris, N., Nielsen, S., Benzodiazepines, methadone and buprenorphine: interactions and clinical management. American Journal on Addictions, Vol. 19, no. 1 (2010), p. 59-72.
Ref.
185671
Lokacija:
SIIS R.1264 Archivo
Palabras clave:
Ansiedad, Buprenorfina, Diagnóstico dual, Drogodependencias, Enfermedades mentales, Estudio epidemiológico, Fármacos, Interacción, Metadona, Mortalidad, Opiáceos, Programas de mantenimiento, Tratamiento, Australia
Ansiedad, Buprenorfina, Diagnóstico dual, Drogodependencias, Enfermedades mentales, Estudio epidemiológico, Fármacos, Interacción, Metadona, Mortalidad, Opiáceos, Programas de mantenimiento, Tratamiento, Australia
Slični predmeti: Benzodiazepines, methadone and buprenorphine: interactions and clinical management
- Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review
- Lack of clinically significant drug interactions between nevirapine and buprenorphine
- Interactions between buprenorphine and antiretrovirals: nucleos(t)ide reverse transcriptase inhibitors (NRTI) Didanosine, Lamivudine, and Tenofovir
- PHARMACODYNAMICS OF DIAZEPAM CO ADMINISTERED WITH METHADONE OR BUPRENORPHINE UNDER HIGH DOSE CONDITIONS IN OPIOID DEPENDENT PATIENTS
- SUBSTITUTION PHARMACOTHERAPIES FOR OPIOID ADDICTION: FROM METHADONE TO LAAM AND BUPRENORPHINE
- COST ANALYSIS OF CLINIC AND OFFICE-BASED TREATMENT OF OPIOID DEPENDENCE: RESULTS WITH METHADONE AND BUPRENORPHINE IN CLINICALLY STABLE PATIENTS